AU3222195A - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- AU3222195A AU3222195A AU32221/95A AU3222195A AU3222195A AU 3222195 A AU3222195 A AU 3222195A AU 32221/95 A AU32221/95 A AU 32221/95A AU 3222195 A AU3222195 A AU 3222195A AU 3222195 A AU3222195 A AU 3222195A
- Authority
- AU
- Australia
- Prior art keywords
- pct
- organic compounds
- leu
- sec
- adhesion molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- AIDS & HIV (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
Abstract
PCT No. PCT/EP95/02966 Sec. 371 Date Jan. 24, 1997 Sec. 102(e) Date Jan. 24, 1997 PCT Filed Jul. 26, 1995 PCT Pub. No. WO96/03430 PCT Pub. Date Feb. 8, 1996Cyclopeptolides of formula I wherein A, B, R, Leu, Leu, C, X and Y are as defined, are inhibitors of adhesion molecule expression and are thus useful for treatment of inflammatory and other diseases which involve increased levels of adhesion molecule expression.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9415168A GB9415168D0 (en) | 1994-07-27 | 1994-07-27 | Organic compounds |
GB9415168 | 1994-07-27 | ||
GBGB9504332.9A GB9504332D0 (en) | 1995-03-03 | 1995-03-03 | Organic compounds |
GB9504332 | 1995-03-03 | ||
PCT/EP1995/002966 WO1996003430A1 (en) | 1994-07-27 | 1995-07-26 | Organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3222195A true AU3222195A (en) | 1996-02-22 |
AU702332B2 AU702332B2 (en) | 1999-02-18 |
Family
ID=26305345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU32221/95A Ceased AU702332B2 (en) | 1994-07-27 | 1995-07-26 | Organic compounds |
Country Status (26)
Country | Link |
---|---|
US (1) | US6013627A (en) |
EP (1) | EP0775158B1 (en) |
JP (1) | JP3425763B2 (en) |
KR (1) | KR100378974B1 (en) |
CN (1) | CN1116304C (en) |
AT (1) | ATE187461T1 (en) |
AU (1) | AU702332B2 (en) |
BR (1) | BR9508342A (en) |
CA (1) | CA2192786C (en) |
CY (1) | CY2225B1 (en) |
CZ (1) | CZ289311B6 (en) |
DE (1) | DE69513837T2 (en) |
DK (1) | DK0775158T3 (en) |
ES (1) | ES2142490T3 (en) |
FI (1) | FI970279A (en) |
GR (1) | GR3032698T3 (en) |
HK (1) | HK1014011A1 (en) |
HU (1) | HUT77388A (en) |
MX (1) | MX9606494A (en) |
NO (1) | NO970340D0 (en) |
NZ (1) | NZ291168A (en) |
PL (1) | PL181990B1 (en) |
PT (1) | PT775158E (en) |
RU (1) | RU2155772C2 (en) |
SK (1) | SK11797A3 (en) |
WO (1) | WO1996003430A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187757B1 (en) | 1995-06-07 | 2001-02-13 | Ariad Pharmaceuticals, Inc. | Regulation of biological events using novel compounds |
US6011136A (en) * | 1995-11-21 | 2000-01-04 | Novartis Ag | Cyclopeptolides |
WO1999014082A1 (en) | 1996-09-18 | 1999-03-25 | Minnesota Mining And Manufacturing Company | Adhesively-bonded inflatable restraint and method of making |
US6365619B1 (en) | 1999-07-22 | 2002-04-02 | Novartis Ag | Treatment of arteriosclerosis |
WO2001014387A1 (en) * | 1999-08-24 | 2001-03-01 | Ariad Gene Therapeutics, Inc. | 28-epirapalogs |
US7067526B1 (en) | 1999-08-24 | 2006-06-27 | Ariad Gene Therapeutics, Inc. | 28-epirapalogs |
AU2002223649A1 (en) * | 2000-10-27 | 2002-05-06 | Novartis Ag | Vegh inhibitors and their use |
GB0028367D0 (en) * | 2000-11-21 | 2001-01-03 | Celltech Chiroscience Ltd | Chemical compounds |
GB0101598D0 (en) * | 2001-01-22 | 2001-03-07 | Novartis Ag | Organic compounds |
AU2003300076C1 (en) | 2002-12-30 | 2010-03-04 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
WO2009089549A1 (en) | 2008-01-11 | 2009-07-16 | Massachusetts Eye & Ear Infirmary | Conditional-stop dimerizable caspase transgenic animals |
WO2014200659A1 (en) | 2013-06-11 | 2014-12-18 | Clontech Laboratories, Inc. | Protein enriched microvesicles and methods of making and using the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4425428A (en) * | 1982-04-08 | 1984-01-10 | Monsanto Company | Novel peptide and peptolide substrates for mammalian collagenase |
US4443367A (en) * | 1982-04-08 | 1984-04-17 | Monsanto Company | Peptide and peptolide substrates for mammalian collagenase |
DE3851268T2 (en) * | 1987-06-19 | 1995-01-26 | Sandoz Ag | Cyclic peptolides. |
DE3832059A1 (en) * | 1988-09-21 | 1990-03-29 | Howaldtswerke Deutsche Werft | DIVE DEPTH CONTROL BLOWOUT VALVE DEVICE |
DE3832362A1 (en) * | 1988-09-23 | 1990-03-29 | Sandoz Ag | NEW CYCLOPEPTOLIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE |
-
1995
- 1995-07-26 CN CN95194370A patent/CN1116304C/en not_active Expired - Fee Related
- 1995-07-26 US US08/776,440 patent/US6013627A/en not_active Expired - Fee Related
- 1995-07-26 RU RU97102700/04A patent/RU2155772C2/en not_active IP Right Cessation
- 1995-07-26 PT PT95928473T patent/PT775158E/en unknown
- 1995-07-26 NZ NZ291168A patent/NZ291168A/en unknown
- 1995-07-26 BR BR9508342A patent/BR9508342A/en not_active Application Discontinuation
- 1995-07-26 AT AT95928473T patent/ATE187461T1/en not_active IP Right Cessation
- 1995-07-26 DE DE69513837T patent/DE69513837T2/en not_active Expired - Fee Related
- 1995-07-26 AU AU32221/95A patent/AU702332B2/en not_active Ceased
- 1995-07-26 SK SK117-97A patent/SK11797A3/en unknown
- 1995-07-26 DK DK95928473T patent/DK0775158T3/en active
- 1995-07-26 MX MX9606494A patent/MX9606494A/en not_active IP Right Cessation
- 1995-07-26 EP EP95928473A patent/EP0775158B1/en not_active Expired - Lifetime
- 1995-07-26 JP JP50548596A patent/JP3425763B2/en not_active Expired - Fee Related
- 1995-07-26 CZ CZ1997221A patent/CZ289311B6/en not_active IP Right Cessation
- 1995-07-26 ES ES95928473T patent/ES2142490T3/en not_active Expired - Lifetime
- 1995-07-26 HU HU9700226A patent/HUT77388A/en unknown
- 1995-07-26 KR KR1019970700504A patent/KR100378974B1/en not_active IP Right Cessation
- 1995-07-26 WO PCT/EP1995/002966 patent/WO1996003430A1/en active IP Right Grant
- 1995-07-26 CA CA002192786A patent/CA2192786C/en not_active Expired - Fee Related
- 1995-07-26 PL PL95317349A patent/PL181990B1/en unknown
-
1997
- 1997-01-23 FI FI970279A patent/FI970279A/en unknown
- 1997-01-27 NO NO970340A patent/NO970340D0/en unknown
-
1998
- 1998-12-23 HK HK98115157A patent/HK1014011A1/en unknown
-
2000
- 2000-02-18 GR GR20000400396T patent/GR3032698T3/en unknown
-
2001
- 2001-06-08 CY CY0100011A patent/CY2225B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATE187461T1 (en) | 1999-12-15 |
KR100378974B1 (en) | 2003-10-08 |
CA2192786A1 (en) | 1996-02-08 |
CZ22197A3 (en) | 1997-05-14 |
BR9508342A (en) | 1997-10-21 |
JPH10504540A (en) | 1998-05-06 |
NO970340L (en) | 1997-01-27 |
GR3032698T3 (en) | 2000-06-30 |
PT775158E (en) | 2000-05-31 |
AU702332B2 (en) | 1999-02-18 |
RU2155772C2 (en) | 2000-09-10 |
US6013627A (en) | 2000-01-11 |
CA2192786C (en) | 2009-06-16 |
MX9606494A (en) | 1997-03-29 |
CZ289311B6 (en) | 2001-12-12 |
ES2142490T3 (en) | 2000-04-16 |
DE69513837T2 (en) | 2000-05-18 |
DE69513837D1 (en) | 2000-01-13 |
PL181990B1 (en) | 2001-10-31 |
HUT77388A (en) | 1998-04-28 |
FI970279A0 (en) | 1997-01-23 |
PL317349A1 (en) | 1997-04-01 |
CY2225B1 (en) | 2003-04-18 |
NZ291168A (en) | 1998-06-26 |
EP0775158A1 (en) | 1997-05-28 |
FI970279A (en) | 1997-01-23 |
HK1014011A1 (en) | 1999-09-17 |
CN1154705A (en) | 1997-07-16 |
WO1996003430A1 (en) | 1996-02-08 |
NO970340D0 (en) | 1997-01-27 |
JP3425763B2 (en) | 2003-07-14 |
DK0775158T3 (en) | 2000-05-22 |
SK11797A3 (en) | 1997-07-09 |
EP0775158B1 (en) | 1999-12-08 |
CN1116304C (en) | 2003-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL312196A1 (en) | Heterocyclic phenyl compounds as inhibitors of cyclooxygenase-2 | |
AU7725596A (en) | Antithrombotic diamines | |
AU2733997A (en) | N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors | |
MX9701893A (en) | Novel prostaglandin synthase inhibitors. | |
LU91145I9 (en) | ||
AU7495096A (en) | New compounds and their compositions having anti-inflammatory and anti-thrombotic activities | |
AU699480B2 (en) | 2,2-Dichloroalkane carboxylic acids, processes for their production and pharmaceutical agents containing these | |
AU3222195A (en) | Organic compounds | |
AU9066498A (en) | Substituted 6-alkylphenanthridines | |
CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
AU2002246317A1 (en) | Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof | |
AU5390900A (en) | Potassium channel blocking agents | |
AP2000001760A0 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. | |
ES2156212T3 (en) | DERIVATIVES OF AZABICICLOHEPTANE N-SUBSTITUTED AS NEUROLEPTICOS, ETC. | |
AU7470098A (en) | Antithrombotic agents | |
AU6722498A (en) | Disubstituted biphenyloxazolines | |
MY115877A (en) | Cyclopeptolides | |
AU7274198A (en) | Antithrombotic agents | |
AU1783700A (en) | 1,8-benzonaphthyridine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |